1-155238215-T-C

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 13P and 1B. PM1PM5PP2PP5_Very_StrongBP4

The NM_000157.4(GBA1):​c.680A>G​(p.Asn227Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,612,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N227R) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000058 ( 0 hom. )

Consequence

GBA1
NM_000157.4 missense

Scores

1
7
10

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:13O:1

Conservation

PhyloP100: 3.36

Publications

55 publications found
Variant links:
Genes affected
GBA1 (HGNC:4177): (glucosylceramidase beta 1) This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]
GBA1 Gene-Disease associations (from GenCC):
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Gaucher disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • Gaucher disease perinatal lethal
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, G2P
  • late-onset Parkinson disease
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Gaucher disease type I
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • Gaucher disease type II
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Gaucher disease type III
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 9 uncertain in NM_000157.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-155238214-AT-CC is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 167132.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 94 curated pathogenic missense variants (we use a threshold of 10). The gene has 3 curated benign missense variants. Gene score misZ: 1.1739 (below the threshold of 3.09). Trascript score misZ: 2.2879 (below the threshold of 3.09). GenCC associations: The gene is linked to late-onset Parkinson disease, Gaucher disease perinatal lethal, Gaucher disease, Gaucher disease type I, Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome, Gaucher disease type II, Parkinson disease, Gaucher disease type III.
PP5
Variant 1-155238215-T-C is Pathogenic according to our data. Variant chr1-155238215-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 4314.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.221823). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000157.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA1
NM_000157.4
MANE Select
c.680A>Gp.Asn227Ser
missense
Exon 6 of 11NP_000148.2P04062-1
GBA1
NM_001005741.3
c.680A>Gp.Asn227Ser
missense
Exon 7 of 12NP_001005741.1P04062-1
GBA1
NM_001005742.3
c.680A>Gp.Asn227Ser
missense
Exon 7 of 12NP_001005742.1P04062-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA1
ENST00000368373.8
TSL:1 MANE Select
c.680A>Gp.Asn227Ser
missense
Exon 6 of 11ENSP00000357357.3P04062-1
GBA1
ENST00000327247.9
TSL:1
c.680A>Gp.Asn227Ser
missense
Exon 7 of 12ENSP00000314508.5P04062-1
GBA1
ENST00000948997.1
c.746A>Gp.Asn249Ser
missense
Exon 8 of 13ENSP00000619056.1

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152108
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000716
AC:
18
AN:
251308
AF XY:
0.0000883
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000582
AC:
85
AN:
1460174
Hom.:
0
Cov.:
32
AF XY:
0.0000564
AC XY:
41
AN XY:
726484
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33396
American (AMR)
AF:
0.0000671
AC:
3
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26126
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39682
South Asian (SAS)
AF:
0.000186
AC:
16
AN:
86194
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000450
AC:
50
AN:
1110550
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000985
AC:
15
AN:
152226
Hom.:
0
Cov.:
30
AF XY:
0.0000672
AC XY:
5
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41552
American (AMR)
AF:
0.0000654
AC:
1
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68010
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000432
Hom.:
0
Bravo
AF:
0.000125
ExAC
AF:
0.0000659
AC:
8
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
not provided (4)
2
-
-
Gaucher disease (3)
2
-
-
Gaucher disease type I (2)
2
-
-
Gaucher disease type II;C0268251:Gaucher disease type III;C0752347:Lewy body dementia;C1842704:Gaucher disease perinatal lethal;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I;C3160718:Parkinson disease, late-onset (2)
1
-
-
Gaucher disease type II (1)
1
-
-
Gaucher disease type II;C0268251:Gaucher disease type III;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I (1)
1
-
-
Gaucher disease type III (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.041
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
19
DANN
Benign
0.46
DEOGEN2
Pathogenic
0.97
D
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.71
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.84
T
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.22
T
MetaSVM
Uncertain
0.43
D
MutationAssessor
Benign
1.6
L
PhyloP100
3.4
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-3.0
D
REVEL
Uncertain
0.49
Sift
Benign
0.24
T
Sift4G
Benign
0.36
T
Polyphen
0.0
B
Vest4
0.61
MVP
0.80
MPC
0.61
ClinPred
0.32
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.51
gMVP
0.90
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs364897; hg19: chr1-155208006; COSMIC: COSV105891369; COSMIC: COSV105891369; API